Forge Biologics to Present at 2021 BIO Digital Conference

COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that it will be delivering a company presentation at BIO Digital, hosted by the Biotechnology Innovation Organization, being held June 10-11 and 14-18, 2021. The presentation features CEO, President and Co-Founder Timothy J. Miller, Ph.D., Chief Medical Officer Maria Escolar, M.D., and Chief Technical Officer David Dismuke, Ph.D.

Event: 2021 BIO Digital, the annual BIO International Convention
Date: June 10-11 and 14-18, 2021
Time: The company presentations will be available on demand during and after the conference for attendees via the link below.
Event Hub session link:
https://biointernationalconvention21.hubb.me/fe/schedule-builder/sessions/795313
(Presentations will be available starting June 10)

Forge will be taking meetings during BIO Digital. Please contact Laura Carfagna at [e-mail] if you are interested in connecting and learning more about how Forge’s manufacturing solutions can take your gene therapy from concept to reality.

About Forge Biologics

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, “The Hearth,” to serve as its headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.

For more information, please visit www.forgebiologics.com.